Abstract

This month, Johannes Czernin, MD, editor-in-chief of The Journal of Nuclear Medicine , asked Henryk Barthel, MD, PhD, a professor in the Klinik und Poliklinik für Nuklearmedizin at the University of Leipzig (Germany), to talk with David Collingridge, PhD, editor-in-chief of The Lancet Oncology and

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.